Ethan Spronk, DVM, a veterinarian at Eichelberger Farms claims that the detection of clinical disease. It is the direct responsibility of the site managers and the skill of function, time and experience spent on farm. On the other hand, the difference in the experience of employees, time expended in the distractions and barn at several times of the year. Such as planting and harvest is the challenge for clinical disease detection.
Constant sound monitoring systems is able to notice the onset of clinical respiratory disease previously with reliability and consistency. Eichelberger Farms of Wayland, Iowa, in association with Boehringer Ingelheim (BI), contributed in the pilot program for discovering the technology that can assist in detecting the onset of health challenges.
Dale Polson, technical manager for BI’s integrated health systems, monitoring and diagnostic business unit entitles that SoundTalks is the audio-based technology. That helps in differentiating and detecting the coughs from other sounds in the environment. And enumerates in the respiratory pain index.
Polson commented “This technology is running 24/7. It detects the onset of respiratory distress episodes as early as possible”. Data from Europe observed and from other placements in the U.S. where the onset of cough episodes detected for causing several diseases.
Furthermore, Spronk said that it is very simple, leading to the detection of targeted treatment. This results in the recovery and faster response, reduced economic loss and enhanced performance at the individual sites. From the perception of the system, this permits more variation of prevention protocols for enhancing profitability and performance.
Spronk claims that “Our goal at Eichelberger Farms was to evaluate cough monitoring technology to see how it could fit not only swine production but also our system”. He even said that “The first step was understanding the ability and limitations of the tool itself. Further, the next step was helping improve the technology. We all realize version one of technology is never the final product and probably doesn’t solve the challenge at hand”.
Moreover, RDIs were constantly monitored and alerts were sent to the prearranged personnel when the system distinguished the substantial rise in RDI. The RDI alert was produced, where diagnostic samples were tested. And collected by PCR for IAV-S, PRRS, PCV2, parainfluenza, and hyopneumoniae.
Additionally, every RDI episode, tracheal swabs, diagnostic samples through oral fluids. The samples of serum tested and collected by PCR for IAV-S, PRRS, PCV2, parainfluenza, and Mycoplasma hyopnuemoniae.
The episodes of RDI diagnose at the site involving Mycoplasma hyopneumoniae, IAV-S (H1N1) and IAV-S (H3N2). Spronk claims that the variations in the types of cough observed within Mycoplasma hyopneumoniae and IAV-S. The distinct patterns diagnose with IAV-S and the other with Mycoplasma hyopneumoniae. The RDI pattern of IAV-S is having a distinct and sharp peak.
The price of implementing this version of the technology will be challenging. Due to the early stages of development for primary projects of evaluation. Also, Polson commented that “The next generation of the Sound Talks technology that addresses these challenges is now being evaluated on some initial farms in the US, Europe, Asia and is expected to be introduced this year”.